SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-18-034994
Filing Date
2018-08-02
Accepted
2018-08-02 08:17:28
Documents
4
Period of Report
2018-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 25293
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 25513
3 image00002.jpg GRAPHIC 2933
4 image00003.jpg GRAPHIC 3799
  Complete submission text file 0001140361-18-034994.txt   61475
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 18986761
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1